Metabiota Status
The company raised an estimated $16 million of Series B venture funding from WP Global Partners and other undisclosed investors on March 7, 2017, putting the company's pre-money valuation at $125 million.
Developer of risk analytic software designed to assess and respond to infectious disease threats through pathogen discovery, disease detection and threat characterization. The company 's risk analytic software offers food risk insights platform that combines powerful analytics with deep understanding of food production systems and microbial risk, enabling customers to make informed risk-based decisions.
Generating Revenue
Privately Held (backing)
Venture Capital-Backed
Thank you @Lloyds_Lab and @LMarks for an amazing Lab experience! The opportunity to connect and learn from leading thinkers in insurance innovation was truly invaluable https://t.co/9tjv8NrcNt
Congratulations to CRESAR and the Metabiota team in #cameroon, led by Ubald Tamoufe, for a successful visit from the Minister Delegate at the Presidency in charge of Defence, a culmination of 20 years of collaborative efforts: https://t.co/6SoEIxxxL5
Thank you to @LANACION and @halconada for hosting our @benoppenheim for a conversation on the global response to Covid-19, and the future of pandemic risk https://t.co/6BrhtqbUT4
Thank you @gdv_de for inviting our @nita_madhav and @benoppenheim to share their thinking on the future of pandemic insurance https://t.co/spd5t6f8b3
The company raised an estimated $16 million of Series B venture funding from WP Global Partners and other undisclosed investors on March 7, 2017, putting the company's pre-money valuation at $125 million.
Thank you @Lloyds_Lab and @LMarks for an amazing Lab experience! The opportunity to connect and learn from leading thinkers in insurance innovation was truly invaluable https://t.co/9tjv8NrcNt
Congratulations to CRESAR and the Metabiota team in #cameroon, led by Ubald Tamoufe, for a successful visit from the Minister Delegate at the Presidency in charge of Defence, a culmination of 20 years of collaborative efforts: https://t.co/6SoEIxxxL5
Thank you to @LANACION and @halconada for hosting our @benoppenheim for a conversation on the global response to Covid-19, and the future of pandemic risk https://t.co/6BrhtqbUT4
Thank you @gdv_de for inviting our @nita_madhav and @benoppenheim to share their thinking on the future of pandemic insurance https://t.co/spd5t6f8b3
Honored to have our @nita_madhav brief the @BioCommission on future pandemic threats, and how their health and economic impacts can be modeled and mitigated https://t.co/gYTgTfnFKf
Great piece in @SPGMarketIntel on how pandemic modeling needs to incorporate governance and behavioral factors to accurately capture the risk, with insights from our @nita_madhav and Jaclyn Guerrero, as well as @GuyCarpenter’s Tom Hettinger https://t.co/w969YdTFOn
We're looking for an exceptional, mission-driven infectious disease modeler / data scientist to join our team. Please help us spread the word! https://t.co/RclmzPxxZK
Our CEO @nita_madhav joined @dylanbgeorge on In-Q-Tel’s Outbreak Analytics and Forecasting podcast, to discuss catastrophe modeling and new techniques to quantify epidemic risk: https://t.co/KV8u2ofJs4
Most visits will take between 1.5 and 2 hours. The agenda for a specific visit depends on your group, its interests and objectives as well as on the host company. A visit may include a company or industry specific presentation, a discussion around a specific product or service, partnership opportunities, a demo, a meeting of the premises, etc.
Add a review